SCHEMBL3783387

SCHEMBL3783387

CC(=O)SOc1ccc(N)c(-c2ccccc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 4/20 0.44
HDAC3 O15379 2/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC2 Q92769 2/20 0.39
HDAC8 Q9BY41 5/20 0.39
ALDH1A1 P00352 2/20 0.38
HSD17B10 Q99714 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.38
NPC1 O15118 3/20 0.37
POLB P06746 1/20 0.37
KDM4E B2RXH2 3/20 0.37
MAPT P10636 2/20 0.37
NCOR2 Q9Y618 1/20 0.37
LMNA P02545 1/20 0.37
PKM P14618 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
IKBKB O14920 1/20 0.36
NCOA1 Q15788 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
RAB9A P51151 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3805098 0.90 CYP19A1 (0.37) BACE1HDAC3HDAC1HDAC2HDAC8
SCHEMBL3790351 0.89 BRD4 (0.36) ALDH1A1KDM4EMAPTSMN1; SMN2
SCHEMBL3786201 0.87 ALDH1A1 (0.39) BACE1HDAC3HDAC1HDAC2HDAC8
SCHEMBL3788301 0.82 ALDH1A1 (0.44) BACE1HDAC3HDAC1HDAC2HDAC8
SCHEMBL3787831 0.81 ALDH1A1 (0.41) HDAC2ALDH1A1HSD17B10KDM4EMAPT
SCHEMBL5045614 0.81 ALDH1A1 (0.39) HDAC3HDAC1HDAC2HDAC8ALDH1A1
SCHEMBL3785527 0.80 BACE1 (0.64) BACE1ALDH1A1NPC1POLBKDM4E
SCHEMBL3792268 0.78 CYP19A1 (0.37) BACE1ALDH1A1NPC1KDM4EMAPT
SCHEMBL3785345 0.77 BRD4 (0.36) ALDH1A1KDM4EMAPTSMN1; SMN2
Acetic Acid SCHEMBL7529999 0.76 PTGDR2 (0.51) BACE1HDAC3HDAC1HDAC2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 BACE1 925/4885HDAC3 2675/4885HDAC1 1686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.